STUDY

Lamisil and griseofulvin kept a rare ringworm away the longest

“Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.” Wingfield AB et al. The British Journal of Dermatology. January 2004

Wingfield AB et al. · The British Journal of Dermatology · January 2004

Randomized trial
The finding

In a four-treatment trial for tinea imbricata, terbinafine and griseofulvin produced remission lasting up to eight weeks after treatment.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized comparison of four oral medicines. The efficacy analysis included 59 people ages 12 to 76.
At a glance

Who was studied and for how long

Analyzed
59 people
Across four groups
Condition
Tinea imbricata
A specific fungal skin infection
Treatment
1 to 4 weeks
Schedules differed by drug
What they did

How the study worked

59 analyzedtinea imbricataRANDOMSPLITTerbinafine12 analyzed · 4 weeksGriseofulvin15 analyzed · 4 weeksItraconazole19 analyzed · 1 weekFluconazole13 analyzed · 4 weeksMEASURED ATFollow-updisease activity59 analyzedtinea imbricataRANDOMSPLITTerbinafine12 analyzed · 4 weeksGriseofulvin15 analyzed · 4 weeksItraconazole19 analyzed · 1 weekFluconazole13 analyzed · 4 weeksMEASURED ATFollow-updisease activity
Random assignmentParticipants received one of four oral antifungals.
Track disease weeklyThe trial monitored disease activity and laboratory tests.
Follow remissionThe authors described how long remission lasted after treatment stopped.
What they found

The results

Remission

Terbinafine and griseofulvin showed significant remission lasting up to eight weeks after treatment. Itraconazole remission was short-lived. The fluconazole group did not show a statistically clear remission.

Adverse events

The study reported none. The small study cannot rule out uncommon problems.

The drugs were tested at different doses and schedules. These results concern tinea imbricata rather than toenail fungus or other forms of ringworm.
How much to trust it

Strengths and limits

Strengths

  • Random assignment
  • Four active treatment groups
  • Follow-up after treatment

Limits

  • Small groups and short follow-up
  • Different treatment durations
  • Specific infection with limited generalizability
Limited confidence. This was a direct trial in a specific infection, with only 59 people in the efficacy analysis.
What it means for you

The takeaway

Specific to tinea imbricata

The terbinafine and griseofulvin regimens showed the most durable remission in this trial.

Pages that cite this study

Read more on Dermapedia

Terms in this study

Words worth knowing

Tinea imbricata

A fungal skin infection that can produce overlapping rings of scale.

Original source

Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.. Br J Dermatol. 2004;150(1):119-26.

PMID 14746625